Baishixing Pharmaceutical boasts a high-caliber team of over 30 professionals and operates two large-scale research laboratories. The company has established in-depth R&D collaborations with leading universities such as Sichuan University, Wuhan University, and Chengdu University, having successfully developed more than 300 products to date.
Our cutting-edge products, including high-quality Semaglutide and Tirzepatide side chains, have entered large-scale commercial production. These innovations have earned widespread recognition from domestic and international clients, laying a solid foundation for the company's sustainable growth.